148 related articles for article (PubMed ID: 37041983)
1. Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses.
Pushparaj P; Nicoletto A; Dopico XC; Sheward DJ; Kim S; Ekström S; Murrell B; Corcoran M; Karlsson Hedestam GB
Front Virol; 2023 Mar; 3():1128253. PubMed ID: 37041983
[TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies.
Pushparaj P; Nicoletto A; Sheward DJ; Das H; Castro Dopico X; Perez Vidakovics L; Hanke L; Chernyshev M; Narang S; Kim S; Fischbach J; Ekström S; McInerney G; Hällberg BM; Murrell B; Corcoran M; Karlsson Hedestam GB
Immunity; 2023 Jan; 56(1):193-206.e7. PubMed ID: 36574772
[TBL] [Abstract][Full Text] [Related]
3. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of a public antibody response to SARS-CoV-2.
Yuan M; Liu H; Wu NC; Lee CD; Zhu X; Zhao F; Huang D; Yu W; Hua Y; Tien H; Rogers TF; Landais E; Sok D; Jardine JG; Burton DR; Wilson IA
bioRxiv; 2020 Jun; ():. PubMed ID: 32577642
[TBL] [Abstract][Full Text] [Related]
5. An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain.
Wu NC; Yuan M; Liu H; Lee CD; Zhu X; Bangaru S; Torres JL; Caniels TG; Brouwer PJM; van Gils MJ; Sanders RW; Ward AB; Wilson IA
bioRxiv; 2020 Jul; ():. PubMed ID: 32743580
[TBL] [Abstract][Full Text] [Related]
6. The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2.
Tian X; Zhu X; Song W; Yang Z; Wu Y; Ying T
Emerg Microbes Infect; 2022 Dec; 11(1):1186-1190. PubMed ID: 35380101
[TBL] [Abstract][Full Text] [Related]
7. Parallel antibody germline gene and haplotype analyses support the validity of immunoglobulin germline gene inference and discovery.
Kirik U; Greiff L; Levander F; Ohlin M
Mol Immunol; 2017 Jul; 87():12-22. PubMed ID: 28388445
[TBL] [Abstract][Full Text] [Related]
8. Paired heavy and light chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses.
Banach BB; Cerutti G; Fahad AS; Shen CH; de Souza MO; Katsamba PS; Tsybovsky Y; Wang P; Nair MS; Huang Y; Urdániz IMF; Steiner PJ; Gutiérrez-González M; Liu L; López Acevedo SN; Nazzari A; Wolfe JR; Luo Y; Olia AS; Teng IT; Yu J; Zhou T; Reddem ER; Bimela J; Pan X; Madan B; Laflin AD; Nimrania R; Yuen KT; Whitehead TA; Ho DD; Kwong PD; Shapiro L; DeKosky BJ
bioRxiv; 2021 Jan; ():. PubMed ID: 33442681
[TBL] [Abstract][Full Text] [Related]
9. Critical steps for computational inference of the 3'-end of novel alleles of immunoglobulin heavy chain variable genes - illustrated by an allele of IGHV3-7.
Thörnqvist L; Ohlin M
Mol Immunol; 2018 Nov; 103():1-6. PubMed ID: 30172112
[TBL] [Abstract][Full Text] [Related]
10. Stereotypic neutralizing V
Kim SI; Noh J; Kim S; Choi Y; Yoo DK; Lee Y; Lee H; Jung J; Kang CK; Song KH; Choe PG; Kim HB; Kim ES; Kim NJ; Seong MW; Park WB; Oh MD; Kwon S; Chung J
Sci Transl Med; 2021 Jan; 13(578):. PubMed ID: 33397677
[TBL] [Abstract][Full Text] [Related]
11. Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM.
Wang J; Yan Y; Xiong W; Song G; Wang Y; Zhao J; Jia Y; Li C; Yu Z; Yu Y; Chen J; Jiao Y; Wang T; Lyu R; Li Q; Ma Y; Liu W; Zou D; An G; Sun Q; Wang H; Xiao Z; Wang J; Qiu L; Yi S
Blood Adv; 2022 Jul; 6(13):4049-4059. PubMed ID: 35537114
[TBL] [Abstract][Full Text] [Related]
12. The functional 3'-end of immunoglobulin heavy chain variable (IGHV) genes.
Thörnqvist L; Ohlin M
Mol Immunol; 2018 Apr; 96():61-68. PubMed ID: 29499482
[TBL] [Abstract][Full Text] [Related]
13. Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoires.
Arcaini L; Zibellini S; Passamonti F; Rattotti S; Lucioni M; Invernizzi R; Merli M; Rizzi S; Boveri E; Rumi E; Astori C; Picone C; Varettoni M; Pascutto C; Paulli M; Lazzarino M
Blood Cells Mol Dis; 2009; 42(3):286-91. PubMed ID: 19250848
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the torafugu (Takifugu rubripes) immunoglobulin heavy chain gene locus.
Fu X; Zhang H; Tan E; Watabe S; Asakawa S
Immunogenetics; 2015 Mar; 67(3):179-93. PubMed ID: 25605268
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2.
Clark SA; Clark LE; Pan J; Coscia A; McKay LGA; Shankar S; Johnson RI; Griffiths A; Abraham J
bioRxiv; 2020 Nov; ():. PubMed ID: 33200128
[TBL] [Abstract][Full Text] [Related]
16. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.
Ghia P; Stamatopoulos K; Belessi C; Moreno C; Stella S; Guida G; Michel A; Crespo M; Laoutaris N; Montserrat E; Anagnostopoulos A; Dighiero G; Fassas A; Caligaris-Cappio F; Davi F
Blood; 2005 Feb; 105(4):1678-85. PubMed ID: 15466924
[TBL] [Abstract][Full Text] [Related]
17. Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations.
Ma J; Bai H; Gong T; Mao W; Nie Y; Zhang X; Da Y; Wang X; Qin H; Zeng Q; Hu F; Qi X; Shi B; Zhang C
Immunol Lett; 2022 Sep; 249():23-32. PubMed ID: 36055412
[TBL] [Abstract][Full Text] [Related]
18. IGHV1, IGHV5 and IGHV7 subgroup genes in the rhesus macaque.
Bible JM; Howard W; Robbins H; Dunn-Walters DK
Immunogenetics; 2003 Mar; 54(12):867-73. PubMed ID: 12671738
[TBL] [Abstract][Full Text] [Related]
19. Germline IGHV3-53-encoded RBD-targeting neutralizing antibodies are commonly present in the antibody repertoires of COVID-19 patients.
Yan Q; He P; Huang X; Luo K; Zhang Y; Yi H; Wang Q; Li F; Hou R; Fan X; Li P; Liu X; Liang H; Deng Y; Chen Z; Chen Y; Mo X; Feng L; Xiong X; Li S; Han J; Qu L; Niu X; Chen L
Emerg Microbes Infect; 2021 Dec; 10(1):1097-1111. PubMed ID: 33944697
[TBL] [Abstract][Full Text] [Related]
20. Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire.
Scheepers C; Shrestha RK; Lambson BE; Jackson KJ; Wright IA; Naicker D; Goosen M; Berrie L; Ismail A; Garrett N; Abdool Karim Q; Abdool Karim SS; Moore PL; Travers SA; Morris L
J Immunol; 2015 May; 194(9):4371-8. PubMed ID: 25825450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
